TrialAdvances in therapy2026

Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension Study.

Lisa A Beck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.